Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Total Non-Current Liabilities (2019 - 2026)

Biodesix filings provide 8 years of Total Non-Current Liabilities readings, the most recent being $71.0 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 14.79% to $71.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $71.0 million, a 14.79% increase, with the full-year FY2025 number at $72.5 million, up 16.85% from a year prior.
  • Total Non-Current Liabilities hit $71.0 million in Q1 2026 for Biodesix, down from $72.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $72.5 million in Q4 2025 to a low of $24.1 million in Q1 2022.
  • Median Total Non-Current Liabilities over the past 5 years was $61.5 million (2024), compared with a mean of $56.5 million.
  • Biggest five-year swings in Total Non-Current Liabilities: tumbled 61.77% in 2022 and later soared 125.05% in 2023.
  • Biodesix's Total Non-Current Liabilities stood at $49.5 million in 2022, then increased by 23.53% to $61.1 million in 2023, then increased by 1.56% to $62.1 million in 2024, then increased by 16.85% to $72.5 million in 2025, then dropped by 2.05% to $71.0 million in 2026.
  • The last three reported values for Total Non-Current Liabilities were $71.0 million (Q1 2026), $72.5 million (Q4 2025), and $72.3 million (Q3 2025) per Business Quant data.